Golden Seeds Cognition Therapeutics LLC

Insider Reports History

Entity
Company
Location
C/O Golden Seeds, Box541473, Flushing, NY
Signature
/s/ Jo Ann Corkran, Co-Chief Executive Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Golden Seeds Cognition Therapeutics LLC:

Stock Role Class Num Shares Value Price $ Report Date Ownership
COGNITION THERAPEUTICS INC 10%+ Owner Common Stock 0 $1.05 Sep 27, 2022 Direct
COGNITION THERAPEUTICS INC 10%+ Owner Series A-1 Convertible Preferred Stock 0 Oct 13, 2021 Direct
COGNITION THERAPEUTICS INC 10%+ Owner Series A-2 Convertible Preferred Stock 0 Oct 13, 2021 Direct
COGNITION THERAPEUTICS INC 10%+ Owner Series B-1 Convertible Preferred Stock 0 Oct 13, 2021 Direct
COGNITION THERAPEUTICS INC 10%+ Owner Series B Convertible Preferred Stock 0 Oct 13, 2021 Direct
COGNITION THERAPEUTICS INC 10%+ Owner Simple Agreement for Future Equity 0 Oct 13, 2021 Direct
COGNITION THERAPEUTICS INC 10%+ Owner Warrant (right to buy) 0 Oct 13, 2021 Direct

Insider Reports Filed by Golden Seeds Cognition Therapeutics LLC

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CGTX COGNITION THERAPEUTICS INC Sep 27, 2022 1 $0 4 Sep 29, 2022 10%+ Owner
CGTX COGNITION THERAPEUTICS INC Oct 13, 2021 13 -$2.99M 4 Oct 15, 2021 10%+ Owner
CGTX COGNITION THERAPEUTICS INC Oct 7, 2021 0 $0 3 Oct 7, 2021 10%+ Owner